STAT+: FDA’s Troy Tazbaz returns to Oracle after a short stint shaping health AI rules
Troy Tazbaz, the outgoing director of the FDA's digital health center, is returning to Oracle as a senior vice president.
Troy Tazbaz, the outgoing director of the Food and Drug Administration’s Digital Health Center of Excellence, is returning to Oracle as a senior vice president for data center planning, according to an update to his LinkedIn profile.
Tazbaz has led the digital health center, which sits within FDA’s medical devices center, as the agency grapples with the complex problem of how to effectively regulate artificial intelligence in medicine. Now, he’s rejoining an organization with close ties to the Trump administration, even as a slew of firings have significantly impacted the teams at FDA that research and review AI products.
It’s unclear whether Tazbaz’s role will touch the company’s health care strategy. But Oracle has recently announced, along with OpenAI and Softbank, a joint venture called Stargate that will invest up to $500 billion in AI infrastructure, including a data center in Texas. Its goals are still murky, but in an announcement of the venture alongside President Donald Trump just after inauguration, Ellison said that applying AI to electronic health records could help doctors “provide health care plans that are much better than they otherwise would be.” Oracle and Tazbaz did not respond to a request for comment in time for publication.
